Background: Atrial natriuretic peptide (ANP) is well known in psychiatric disorders to modulate hypothalamic-pituitary-adrenal axis activity. Disturbances of ANP have been described in early abstinent alcohol-dependent patients. This is the first longitudinal investigation on cytosine-phosphatidyl-guanine (CpG)-island promoter methylation of the ANP gene in the blood of tobacco-dependent patients. Methods: In a longitudinal approach, we investigated whether changes in ANP serum levels correlated to CpG methylation of the respective gene promoters on days 1, 7, and 14 of tobacco withdrawal. Results and Conclusion: Compared to non-smokers, promoter-related deoxyribonucleic acid methylation of the ANP promoter was significantly elevated on days 7 and 14 of withdrawal in tobacco-dependent patients. Baseline methylation status of the ANP promoter was not significantly different from controls, arguing for an impaired regulation during withdrawal.

Keywords:
Tobacco dependence, Withdrawal, Atrial natriuretic peptide, Epigenetic regulation
1.
Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R: Mortality from smoking worldwide. Br Med Bull 1996; 52: 12–21.
2.
Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R: Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control 2006; 15: 464–471.
3.
Fiore MC: Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care 2000; 45: 1196–1199.
4.
Tapinc DE, Ilgin R, Kaya E, Gozen O, Ugur M, Koylu EO, Kanit L, Keser A, Balkan B: Gene expression of pro-opiomelanocortin and melanocortin receptors is regulated in the hypothalamus and mesocorticolimbic system following nicotine administration. Neurosci Lett 2017; 637: 75–79.
5.
Gomes Ada S, Toffolo MC, Keulen HV, Castro e Silva FM, Ferreira AP, Luquetti SC, Mendes LL, Volp AC, de Aguiar AS: Influence of the leptin and cortisol levels on craving and smoking cessation. Psychiatry Res 2015; 229: 126–132.
6.
Imura H, Nakao K, Itoh H: The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 1992; 13: 217–249.
7.
Colao A, Pivonello R, Ferone D, Faggiano A, Facciolli G, Di Somma C, Boudouresque F, Oliver C, Lombardi G: Effect of corticotrophin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease. Clin Endocrinol (Oxf) 1998; 49: 77–84.
8.
Koopmann A, Bez J, Lemenager T, Hermann D, Dinter C, Reinhard I, Schuster R, Wiedemann K, Winterer G, Kiefer F: The effect of nicotine on HPA axis activity in females is modulated by the FKBP5 genotype. Ann Hum Genet 2016; 80: 154–161.
9.
Koopmann A, Lemenager T, Wolf ND, Reinhard I, Hermann D, Koch J, Wiedemann K, Kiefer F: The impact of atrial natriuretic peptide on anxiety, stress and craving in patients with alcohol dependence. Alcohol Alcohol 2014; 49: 282–286.
10.
Wiedemann K, Jahn H, Yassouridis A, Kellner M: Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 2001; 58: 371–377.
11.
Kiefer F, Jahn H, Schick M, Wiedemann K: Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology (Berl) 2002; 164: 239–240.
12.
Glahn A, Riera Knorrenschild R, Rhein M, Haschemi Nassab M, Groschl M, Heberlein A, Muschler M, Frieling H, Bleich S, Hillemacher T: Alcohol-induced changes in methylation status of individual CpG sites, and serum levels of vasopressin and atrial natriuretic peptide in alcohol-dependent patients during detoxification treatment. Eur Addict Res 2014; 20: 143–150.
13.
Semmler A, Heese P, Stoffel-Wagner B, Muschler M, Heberlein A, Bigler L, Prost JC, Frieling H, Kornhuber J, Banger M, Bleich S, Hillemacher T, Linnebank M: Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol 2015; 49: 97–101.
14.
Dilling H, Freyberger HJ, Cooper JE, Weltgesundheitsorganisation: Taschenführer zur ICD-10-Klassifikation psychischer Störungen mit Glossar und Diagnostischen Kriterien sowie Referenztabellen ICD-10 vs. ICD-9 und ICD-10 vs. DSM-IV-TR: 8, überarbeitete Auflage unter Berücksichtigung der Ã'nderungen gemäss ICD-10-GM (German Modification) 2016 ed. Bern Hogrefe; Hogrefe, 2016.
15.
American Psychiatric Association, Falkai P, Wittchen H, Döpfner M, Gaebel W, Maier W, Rief W, Say H, Zaudig M: Diagnostische Kriterien DSM-12: 1 Auflage ed. Göttingen: Hogrefe, 2015.
16.
Hillemacher T, Kahl KG, Heberlein A, Muschler MA, Eberlein C, Frieling H, Bleich S: Appetite- and volume-regulating neuropeptides: role in treating alcohol dependence. Curr Opin Investig Drugs 2010; 11: 1097–1106.
17.
Tiffany ST, Drobes DJ: The development and initial validation of a questionnaire on smoking urges. Br J Addict 1991; 86: 1467–1476.
18.
Bi Y, Zhang Y, Li Y, Yu D, Yuan K, Tian J: 12h abstinence-induced right anterior insula network pattern changes in young smokers. Drug Alcohol Depend 2017; 176: 162–168.
19.
Mosher MJ, Melton PE, Stapleton P, Schanfield MS, Crawford MH: Patterns of DNA methylation across the leptin core promoter in four diverse Asian and North American populations. Hum Biol 2016; 88: 121–135.
20.
Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, Murata S, Terasaki T: Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier. J Cereb Blood Flow Metab 2011; 31: 457–466.
21.
Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, Weidinger S, Lattka E, Adamski J, Peters A, Strauch K, Waldenberger M, Illig T: Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 2013; 8:e63812.
22.
Harlid S, Xu Z, Panduri V, Sandler DP, Taylor JA: CpG sites associated with cigarette smoking: analysis of epigenome-wide data from the Sister Study. Environ Health Perspect 2014; 122: 673–678.
23.
Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, Belvisi MG, Brown R, Vineis P, Flanagan JM: Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 2013; 22: 843–851.
24.
Ambatipudi S, Cuenin C, Hernandez-Vargas H, Ghantous A, Le Calvez-Kelm F, Kaaks R, Barrdahl M, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Naska A, Palli D, Krogh V, Polidoro S, Tumino R, Panico S, Bueno-de-Mesquita B, Peeters PH, Quiros JR, Navarro C, Ardanaz E, Dorronsoro M, Key T, Vineis P, Murphy N, Riboli E, Romieu I, Herceg Z: Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study. Epigenomics 2016; 8: 599–618.
25.
Joehanes R, Just AC, Marioni RE, Pilling LC, Reynolds LM, Mandaviya PR, Guan W, Xu T, Elks CE, Aslibekyan S, Moreno-Macias H, Smith JA, Brody JA, Dhingra R, Yousefi P, Pankow JS, Kunze S, Shah SH, McRae AF, Lohman K, Sha J, Absher DM, Ferrucci L, Zhao W, Demerath EW, Bressler J, Grove ML, Huan T, Liu C, Mendelson MM, Yao C, Kiel DP, Peters A, Wang-Sattler R, Visscher PM, Wray NR, Starr JM, Ding J, Rodriguez CJ, Wareham NJ, Irvin MR, Zhi D, Barrdahl M, Vineis P, Ambatipudi S, Uitterlinden AG, Hofman A, Schwartz J, Colicino E, Hou L, Vokonas PS, Hernandez DG, Singleton AB, Bandinelli S, Turner ST, Ware EB, Smith AK, Klengel T, Binder EB, Psaty BM, Taylor KD, Gharib SA, Swenson BR, Liang L, DeMeo DL, O'Connor GT, Herceg Z, Ressler KJ, Conneely KN, Sotoodehnia N, Kardia SL, Melzer D, Baccarelli AA, van Meurs JB, Romieu I, Arnett DK, Ong KK, Liu Y, Waldenberger M, Deary IJ, Fornage M, Levy D, London SJ: Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet 2016; 9: 436–447.
26.
Tsaprouni LG, Yang TP, Bell J, Dick KJ, Kanoni S, Nisbet J, Vinuela A, Grundberg E, Nelson CP, Meduri E, Buil A, Cambien F, Hengstenberg C, Erdmann J, Schunkert H, Goodall AH, Ouwehand WH, Dermitzakis E, Spector TD, Samani NJ, Deloukas P: Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenetics 2014; 9: 1382–1396.
27.
Schwartz J, Weiss ST: Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol 1994; 4: 236–242.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.